|
Terry Moody, Ph.D.
Dr. Terry Moody obtained a Ph.D. in Chemistry in 1978 from the California Institute of Technology in Pasadena, California. Subsequently, he was a postdoctoral fellow at the National Institute in Mental Health, where he conducted research on peptide growth factors in the central nervous system. He joined the faculty of The George Washington University Medical Center in 1980 and subsequently became a Professor in Biochemistry and Molecular Biology. During this period, he conducted research on peptide growth factors in lung cancer and was supported by numerous R01 grants from the NCI. In particular, he discovered that bombesin (BB)-like peptide were autocrine growth factors in small cell lung cancer. In 1993, he became a section chief of Experimental Biochemistry at the NCI. He discovered that vasoactive intestinal peptides (VIP) were autocrine growth factors for lung and breast cancer. In addition, he found that BB receptor antagonists, VIP receptor antagonists, and thymosin-like peptides prevented lung carcinogenesis in animal models. These results suggested that endogenous BB- and VIP-like peptides might function as promoters of lung carcinogenesis, whereas thymosina1 stimulated the immune system in the mice. Currently, he is a special assistant in the Office of the Director at the Center for Cancer Research at the NCI. Dr. Moody has published more than 200 manuscripts and 2 books on the biochemistry of peptides and growth factors in the central nervous system and cancer cells. He is a member of the American Association for the Advancement of Science, the American Society for Biochemistry and Molecular Biology, the New York Academy of Science, SON, the American Association for Cancer Research, the International Association for the Study of Lung Cancer, and the American Association of University Professors. Dr. Moody serves on the editorial advisory boards of Peptides, Molecular Neuroscience, Life Science, and Lung Cancer. He was a member of the National Science Foundation panel on molecular and cellular neurobiology (1986-1988) and the NIH Neurology B2 study section (1990-1995). He has organized the George Washington University Spring Symposium (1985 and 1992) and the Summer Neuropeptide Conference (1999-2002).
March 2002
|
